MedPath

High-intensity Interval Training Versus Moderate Continuous Training in Heart Transplant Recipients.

Not Applicable
Completed
Conditions
Heart Transplant Recipients
Interventions
Other: continuous moderate training
Other: high intense interval training
Registration Number
NCT01914406
Lead Sponsor
Bispebjerg Hospital
Brief Summary

The aim of this study was to examine the effects of high intensity aerobic interval training (AIT) versus moderate continuous training (CON) in heart transplant recipients.

Detailed Description

Clinically stable heart transplant recipients \> 12 month or more after HTx, age \> 18 years, willing and capable of giving written informed consent for study participation and anticipated to be able to participate in the study for 12 months were included from the Heart Centre, Rigshospitalet, Copenhagen University Hospital.

Patients were excluded due to unstable condition or postoperative complications, recent severe rejection episodes (\>H1R \< 3 month), physical disabilities which prevent participation and re-transplantation or multi-organtransplantation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

-stable Heart transplant recipients > 12 month or more after HTx, age > 18 years,< 80. willing and capable of giving written informed consent for study participation.

Exclusion Criteria

unstable condition postoperative complications, recent severe rejection episodes (>H1R < 3 month), re-transplantation or multi-organtransplantation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
continuous moderate trainingcontinuous moderate trainingContinued exercise 45 min.
high intense interval traininghigh intense interval trainingEach AIT session consisted a 10 minute warm-up period followed by 16 minutes of interval training consisting of intervals of 4-3-2 and 1 minutes duration at 85-95% of their peak capacity separated by 2-4 min active rest.
Primary Outcome Measures
NameTimeMethod
VO2peakbaseline test (inclusion), follow-up 1(3 month), follow-up 2 (8 month), follow-up 3 (11 month).

baseline test before randomization

1. follow-up after 12 weeks of exercise

2. follow-up after 5 month washout.

3. follow-up after second 12 weeks period of exercise.

Secondary Outcome Measures
NameTimeMethod
Endothelial function (endoPAT)baseline test (inclusion), follow-up 1(3 month), follow-up 2 (8 month), follow-up 3 (11 month).

After the release of the cuff the hyperemic response was recorded and the reactive hyperemia index (RHI) was calculated automatic independent of operator. (endoPAT)

Quality of Life (QoL)SF-36baseline test (inclusion), follow-up 1(3 month), follow-up 2 (8 month), follow-up 3 (11 month).

SF-36, information on Quality of Life

Bloodsamples/biomarkers.baseline test (inclusion), follow-up 1(3 month), follow-up 2 (8 month), follow-up 3 (11 month).

Samples cooled on ice, centrifuged for 10 minutes and the plasma transferred to microtubes and stored at -80°C. Biomarkers analysed at department of biomedicine at University of Copenhagen.

HADS-a, HADS-d anxiety and depressionbaseline test (inclusion), follow-up 1(3 month), follow-up 2 (8 month), follow-up 3 (11 month).

Symptoms of anxiety and depression measured by the Hospital Anxiety and Depression Scale (HADS).

augmentation index (AI), endoPATbaseline test (inclusion), follow-up 1(3 month), follow-up 2 (8 month), follow-up 3 (11 month).

Augmentation index (AI)derived from pulse wave analyses and is a measure of arterial stiffness, (EndoPAT).

Trial Locations

Locations (1)

Cardiac Rehabilitation, Bispebjerg University Hospital

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath